Trial Profile
A Randomised, Double-blind, Placebo-controlled Trial to Assess the Safety, Tolerability and Pharmacokinetics of GS-9411 in Healthy Male Volunteers
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 09 May 2014
Price :
$35
*
At a glance
- Drugs GS 9411 (Primary)
- Indications Cystic fibrosis
- Focus Adverse reactions
- Sponsors Gilead Sciences
- 09 May 2014 New trial record